ROYALTY PHARMA PLC: Diferență între versiuni
Admin (discuție | contribuții) (csv2wiki) |
Admin (discuție | contribuții) Fără descriere a modificării |
||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei ROYALTY PHARMA PLC listata cu simbolul US.RPRX | Pagina dedicata companiei ROYALTY PHARMA PLC listata cu simbolul US.RPRX | ||
==Descriere companie== | ==Descriere companie== | ||
Royalty Pharma plc (https://www.royaltypharma.com) is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in commercial products and development-stage product candidates. Its portfolio investments include AbbVie and J& | Royalty Pharma plc (https://www.royaltypharma.com) is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in commercial products and development-stage product candidates. Its portfolio investments include AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko, Trikafta and OXLUMO. | ||
==Grafic actiuni companie== | |||
<iframe key="tradeville" path="graficSimbol/US.RPRX" /> | |||
==Ultimele stiri despre ROYALTY PHARMA PLC (US.RPRX)== | ==Ultimele stiri despre ROYALTY PHARMA PLC (US.RPRX)== | ||
| Linia 13: | Linia 14: | ||
addfirstcategorydate=false | addfirstcategorydate=false | ||
</dynamicpagelist> | </dynamicpagelist> | ||
[[Categorie:US.RPRX]][[Categorie:Stiri despre companii]] | [[Categorie:US.RPRX]][[Categorie:Stiri despre companii]] | ||
Versiunea de la data 18 septembrie 2024 20:26
Pagina dedicata companiei ROYALTY PHARMA PLC listata cu simbolul US.RPRX
Descriere companie
Royalty Pharma plc (https://www.royaltypharma.com) is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in commercial products and development-stage product candidates. Its portfolio investments include AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko, Trikafta and OXLUMO.
Grafic actiuni companie